Research shows that during the Ebola virus epidemic in West Africa, the ReEBOV Antigen Rapid Test, developed by Corgenix, showed promise as a bedside rapid Ebola test, successfully detecting Ebolavirus. (Harvard), (Corgenix), (The Lancet)